Recent epidemiologic and experimental evidence suggests that serum uric acid (UA) is an independent risk factor for cardiovascular and renal diseases. However, endothelial dysfunction is an early predictor of cardiovascular events, particularly in hypertensive patients. For assessment of the association between UA and endothelial function, 217 (108 men, 109 women; aged 48.0 ؎ 10.6 yr) white never-treated hypertensive patients were studied. All patients underwent the following procedures: BP measurements, laboratory tests (C-reactive protein [CRP], insulin resistance by homeostasis model assessment, serum creatinine, and UA), and endothelial function evaluated by intra-arterial infusion of acetylcholine (ACh). Serum creatinine, CRP, and maximal vasodilatory response to ACh were related to the UA (all P < 0.0001). In the multiple regression analysis, serum UA ranked as the third correlate of peak of forearm blood flow predictor, after homeostasis model assessment and CRP. The data show an independent link between UA and endothelial function, also in a statistical model that included CRP. In conclusion, the data demonstrate an inverse and significant relationship between UA and ACh-stimulated vasodilation in patients with uncomplicated, untreated essential hypertension, independent of traditional cardiovascular risk factors. Probably, the chronic inflammation that was documented in these patients may be considered the mechanistic link between serum UA and vascular damage.
xtensive epidemiologic and experimental evidence now suggests that serum uric acid (UA) is a relevant and independent risk factor for cardiovascular and renal disease, particularly in patients with hypertension, heart failure, or diabetes. Hyperuricemia predicts mortality in patients with heart failure (1) or coronary heart disease (2), cerebrovascular events in individuals with diabetes (3), and cardiac ischemia in hypertension (4) . The mechanism(s) by which UA may engender organ damage is still incompletely understood, but there is increasing evidence that endothelial dysfunction is a fundamental mechanism whereby this substance may affect cardiovascular and renal function and structure (5) . In a series of elegant experiments in rats, it was demonstrated that hyperuricemia, induced by an uricase inhibitor, triggers hypertension and impairs nitric oxide (NO) generation in the macula densa, whereas both hypertension and renal injury are reduced by treatment with the NO precursor l-arginine (6, 7) . Although the relationship between UA and human hypertension has been investigated in several prospective studies (8) , until now, the relationship between UA levels and endothelial dysfunction has been explored only in a study that combined seemingly healthy individuals and patients with preexisting cardiovascular diseases of various severity (9) or in individuals at increased cardiovascular risk (10) . In this study, serum UA was inversely related to flow-mediated vasodilation, but this relationship was much weakened by adjustment for other risk factors and remained significant only in men.
Essential hypertension is consistently associated with endothelial dysfunction (11) , and hyperuricemia is a strong predictor of hypertension and BP progression (12) . Therefore, individuals with essential hypertension constitute an interesting population in which to investigate the relationship between UA and endothelial dysfunction. Of note, focusing on a drug-free population without cardiovascular complications seems important because these factors are notorious confounders in the interpretation of hemodynamic tests of endothelial function (13) .
In 1993, at the Department of Experimental and Clinical Medicine of Magna Graecia University, we started a series of systematic studies of endothelial function in primary, uncomplicated hypertension. In this study, we used a sample extracted from this large database to investigate the relationship between the endothelium-dependent vasodilatory response to acetylcholine (ACh) in the forearm, UA, renal function, and inflammation in a large group of patients with uncomplicated, never-treated essential hypertension and serum creatinine within the normal range.
Materials and Methods

Patients
A total of 217 never-treated individuals with uncomplicated essential hypertension (108 men and 109 women; age range 32 to 73 yr; mean 48.0 Ϯ 10.6 yr; all white) were studied. These individuals were selected from among approximately 3500 individuals who were referred to the hypertension clinic of the University Hospital between September 1993 and January 2003, and 138 were included in our previous study (14) . To be selected, patients had to have newly diagnosed essential hypertension and had to have never received antihypertensive medications. Renal function was evaluated by serum creatinine (Յ1.5 mg/dl) and by calculated GFR as Modification of Diet in Renal Disease formula (15) ; in addition, all patients had to be proteinuria-free on the dipstick test. Furthermore, they had to have simultaneous measurements of endothelial function, C-reactive protein (CRP), insulin resistance, and the full record of classical risk factors. These 217 patients did not significantly differ from the whole series of 500 of never-treated individuals who had uncomplicated hypertension and were studied in the same institution in the same time interval (data presented as an extra table and provided on request to interested readers). No patient was being treated with allopurinol, and none had a history of gout. Furthermore, no patient declared to drink Ͼ60 ml/d ethanol. None of the patients had a history or clinical evidence of angina, myocardial infarction, valvular heart disease, diabetes, hypercholesterolemia, peripheral vascular disease, coagulopathy, or any disease that predisposes to vasculitis or Raynaud's phenomenon. Causes of secondary hypertension were excluded by appropriate investigations, including measurement of plasma renin activity and aldosterone, Doppler studies of the renal arteries, and/or renal scintigraphy or renal angiography. The local ethics Committee approved the study, and all participants gave written informed consent for all procedures.
Forearm Blood Flow Measurement
These studies were begun at 9 a.m., after patients had fasted overnight, with the patients lying supine in a quiet, air-conditioned room (22 to 24°C). For measurement of the vasodilatory response to ACh, we adopted the protocol suggested by Panza et al. (11) . Patients refrained from smoking at least 4 h before starting the hemodynamic study and rested 30 min after artery cannulation to reach a stable baseline before data collection. Standardization of the technique in our laboratory was described elsewhere (16) . Forearm blood flow and arterial pressure were measured during intra-arterial infusion of saline, ACh, and sodium nitroprusside (SNP) at increasing doses. Endothelium-dependent and -independent vasodilation was assessed by a dose-response curve to intra-arterial ACh infusions (7.5, 15, and 30 g/ml per min, each for 5 min) and SNP infusions (0.8, 1.6, and 3.2 g/ml per min, each for 5 min), respectively. The sequence of administration of ACh and SNP was randomized to avoid any bias related to the order of drug infusion. The drug infusion rate, adjusted for forearm volume of each patient, was 1 ml/min. For this study, the maximal response to ACh and the area under the response curve to ACh were considered for statistical analysis.
Laboratory Methods
Serum creatinine and UA were measured in the routine laboratory by an automated technique based on the measurement of Jaffe chromogen and by the URICASE/POD (Boehringer Mannheim, Mannheim, Germany) method implemented in an autoanalyzer. CRP was measured by a high-sensitivity turbidimetric immunoassay (Behring, Marburg, Germany). Insulin resistance was estimated by the homeostasis model assessment (HOMA-R index) from the fasting glucose and insulin concentrations according to the equation HOMA ϭ [insulin (U/ml ϫ glucose (mmol/L)]/22.5 (17) .
Statistical Analyses
Data are expressed as mean Ϯ SD or as percentage frequency, and comparisons between groups were made by one-way ANOVA or the 2 test, as appropriate. Relationships between paired parameters were analyzed by Pearson product moment correlation coefficient. To test the independent relationship between the response to ACh and serum UA, we constructed multivariate linear and logistic models that included all classical cardiovascular risk factors: Age, gender, smoking, body mass index, BP, LDL and HDL cholesterol, triglycerides, glucose, and smoking. Data are expressed as standardized regression coefficient (␤) or as odds ratios and 95% confidence interval and probability value, as appropriate. All calculations were made with a standard statistical package (SPSS for Windows version 9.0.1; SPSS, Inc., Chicago, IL).
Results
Average UA in hypertensive patients was 4.8 Ϯ 1.7 mg/dl, and 25% of them displayed hyperuricemia (serum UA Ն6.5 mg/dl in men and Ͼ6.0 mg/dl in women). Patients were grouped into three tertiles on the basis of their serum UA. As shown in Table 1 , patients in the third tertile (i.e., those who displayed higher serum UA) were older and had higher serum creatinine and CRP than patients in the other two tertiles. Tertiles did not differ with regard to BP and heart rate, serum glucose, LDL and HDL cholesterol, or the proportion of smokers. Notably, peak of forearm blood flow was markedly lower (P Ͻ 0.001) in patients in the third tertile than in those in the other two tertiles. All patients showed normal endotheliumindependent vasodilation in response to SNP infusion ( Table 1) . The relationship between UA and endothelial-dependent forearm blood flow response to ACh was analyzed further by linear regression analysis that confirmed a highly significant association between the two variables ( Figure 1 ). Of note, serum UA was linearly related also with creatinine (r ϭ 0.30, P Ͻ 0.0001) as well as with serum CRP (r ϭ 0.27, P Ͻ 0.0001; Figure 1 ) and with the estimated GFR (r ϭ 0.24, P Ͻ 0.0001). The peak percentage increase in hyperuricemic versus normouricemic patients was significantly lower (266.7 Ϯ 157.5 versus 361.7 Ϯ 195.1; P Ͻ 0.0001). In addition, by adopting a cutoff value of 400% (an accepted threshold) of increase in forearm blood flow, the hyperuricemic group showed a more significant prevalence of patients with endothelial dysfunction (72 versus 62%; P ϭ 0.011). Furthermore serum UA was significantly higher in individuals with full-blown metabolic syndrome than in those without this syndrome (5.1 Ϯ 1.7 versus 4.4 Ϯ 1.6; P ϭ 0.018) but independent of HOMA-R index (r ϭ 0.06, NS).
Multivariate Analyses
In a multivariate analysis, only systolic BP (␤ ϭ 0.22, P ϭ 0.025), age (␤ ϭ 0.15, P ϭ 0.023), serum creatinine (␤ ϭ 0.18, P ϭ 0.013), and CRP (␤ ϭ 0.21, P ϭ 0.0003) were independently related with serum UA. To test the independence of the association between serum UA and the forearm blood flow response to ACh from other risk factors, we performed a multiple regression analysis that included the full series of demographic and cardiovascular risk factors listed in Table 1 . In this analysis (Table 2) , serum UA ranked as the third correlate of peak of forearm blood flow after HOMA index and CRP. The risk for endothelial dysfunction that was associated with UA was analyzed further in a logistic regression analysis that showed that a 1-mg/dl increase in the serum concentration of this substance signals a 41% higher risk for endothelial dysfunction (Table 3) .
Discussion
This study shows that serum UA concentration in individuals with uncomplicated, untreated essential hypertension is associated with endothelial dysfunction independent of tradi- In particular, 1 mg/dl of serum UA reduces by 41% the AChstimulated vasodilation. In addition, our data demonstrate that serum UA levels goes in parallel with serum creatinine and GFR, both markers of impairment of renal function. Endothelial dysfunction, commonly observed in cardiovascular and renal diseases, is attributed to oxidative stress, dyslipidemia, accumulation of endogenous inhibitors of NO synthase, genetic factors, and other causes (13) . Recent experimental data directly implicate UA in endothelial dysfunction (18, 19) , but few studies were conducted in humans and available data are controversial. In patients with heart failure (20) , with type 2 diabetes (21), at increased cardiovascular risk (10) , and with hypercholesterolemia but not in patients with essential hypertension (22) , allopurinol, a xanthine oxidase inhibitor that lowers UA and interacts with anion superoxide generation (23), improves endothelial dysfunction. In the study of Mercuro et al. (10) , the beneficial effect of allopurinol could have been a direct consequence of the reduced UA levels rather than of superoxide anions mediated by xanthine oxidase inhibition because of the close correlation found between the amount of that decrease and the improvement of endothelial function. It is interesting that recent findings suggest that fructose-induced hyperuricemia reduce endothelial NO levels and induce insulin resistance, components of the metabolic syndrome (24) In healthy humans, there is an inverse circadian relationship between serum UA levels and NO (25) , supporting the hypothesis that UA impairs endothelial function, even if this relationship does not necessarily suggest a causal and unidirectional relationship between UA and NO bioavailability. In keeping with this, l-arginine reduces serum UA (9), a phenomenon that supports the reverse hypothesis that UA is modified by increased NO availability. Short-term infusion of UA in normal individuals does not modify the forearm blood response to basal blood flow and responses to ACh, SNP, and l-NGmonomethylarginine (26) . Although the acute response to UA may differ from the response to chronic exposure to this substance, collectively these observations indicate that UA should not be viewed necessarily as a vasculotoxic substance. UA may act as an important intracellular free radical scavenger during physical exercise (27) , and an increased synthesis of UA in endothelial cells may be a physiologic response to oxidative stress (28) . Therefore, it is unclear whether UA impairs endothelial function in vivo in humans. The question is relevant mainly because this alteration is an early, fundamental step in the development of atherosclerosis and a prerequisite for UA's triggering vasculopathy in experimental models.
High UA levels have been associated with organ damage in hypertensive patients and are considered an integral part of the biochemical alterations that compound the metabolic syndrome. Indeed, serum UA is higher in hypertensive patients with target organ damage (29) , as well as in seemingly healthy men (30) .
The study of the hemodynamic response to ACh is an accepted, well-standardized, and reproducible (31) means for testing endothelial function in vivo in humans. Although forearm microcirculation is not a target organ for atherosclerosis, its response to ACh represents an independent predictor for cardiovascular events (16) . Studying endothelial function in individuals with uncomplicated, untreated essential hypertension therefore may provide relevant information on the effect of UA on the endothelium. Of note, we found that UA was inversely related with the hemodynamic response to ACh. In theory, such an association may be the mere expression of subtle renal insufficiency in hypertensive patients. In fact, in a previous study, we reported that endothelial dysfunction is strongly associated with mild and moderate degrees of renal function impairment in hypertensive patients (14) . Furthermore, such an association may result from the confounding effect of the metabolic syndrome, a possibility emphasized by our findings that UA was higher in patients with full-blown metabolic syndrome than in those without such syndrome. However, both multiple linear and logistic regression analyses that considered all major cardiovascular risk factors and serum creatinine as well showed that the link between UA and endothelial dysfunction was largely independent of these variables. Therefore, our data suggest that chronic exposure to mild hyperuricemia is a factor that contributes to endothelial dysfunction in patients with uncomplicated, untreated primary hypertension. Inflammation may be a relevant pathway in cardiovascular damage caused by UA (32) . The hypothesis that UA may act as a proinflammatory agent is supported by observations of patients with heart failure (33) and more recently in an elegant experimental study (19) . These data demonstrate that UA can stimulate the synthesis of CRP, and that might be one of the mechanisms underlying the endothelial dysfunction. Our data showing an independent link between UA and CRP suggest that chronic exposure to mild hyperuricemia may be a factor that contributes to microinflammation and raised CRP in individuals with essential hypertension. In this regard, it is important to note that in this and in a previous study (34) , we found that CRP is a stronger correlate of endothelial function than creatinine. The observation that the UA-endothelial function link remains strong also in a statistical model that included CRP suggests that inflammation-independent pathways play a significant role in the putative effect of UA on endothelial function. Our study has several limitations. The cross-sectional design does not allow establishment of the direction of causality; therefore, our observations remain to be confirmed in prospective observational and interventional studies. Second, ours is a tertiary referral center; therefore, patients who enrolled in this survey represent a selected population that is not representative of primary care. Third, we cannot exclude that UA constitutes a measure of residual confounding from Framingham risk factors, e.g., that relatively higher UA concentration may be the expression of a longer exposure to hypertension and/or to dyslipidemia.
Hyperuricemia in individuals with essential hypertension is associated with endothelial dysfunction. This association, which is independent of classical risk factors, CRP, and insulin resistance, supports the hypothesis that UA plays a significant role in this alteration in humans. Interventional studies are needed to clarify the nature of this association.
